Media Room

New Study: the PCA3 test could be useful to predict the outcome of an initial prostate biopsy

April 22, 2010

New studies show DiagnoCure’s PCA3 prostate cancer marker can help guide repeat prostate biopsy decisions and predict risk of aggressive cancer

March 8, 2010, 09:40

Beginning of a U.S. clinical study intended to secure U.S. FDA regulatory approval of the PROGENSA PCA3 assay

August 27, 2009